TW200801075A - Dendritic polymers with enhanced amplification and interior functionality - Google Patents

Dendritic polymers with enhanced amplification and interior functionality

Info

Publication number
TW200801075A
TW200801075A TW095122332A TW95122332A TW200801075A TW 200801075 A TW200801075 A TW 200801075A TW 095122332 A TW095122332 A TW 095122332A TW 95122332 A TW95122332 A TW 95122332A TW 200801075 A TW200801075 A TW 200801075A
Authority
TW
Taiwan
Prior art keywords
dendritic
dendritic polymers
interior
reagents
functionality
Prior art date
Application number
TW095122332A
Other languages
English (en)
Other versions
TWI356709B (en
Inventor
Donald A Tomalia
Douglas R Swanson
Baohua Huang
Veera Reddy Pulgam
Original Assignee
Dendritic Nanotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/013864 external-priority patent/WO2006065266A2/en
Application filed by Dendritic Nanotechnologies Inc filed Critical Dendritic Nanotechnologies Inc
Publication of TW200801075A publication Critical patent/TW200801075A/zh
Application granted granted Critical
Publication of TWI356709B publication Critical patent/TWI356709B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/005—Dendritic macromolecules
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0001—Post-treatment of organic pigments or dyes
    • C09B67/0004—Coated particulate pigments or dyes
    • C09B67/0008—Coated particulate pigments or dyes with organic coatings
    • C09B67/0013—Coated particulate pigments or dyes with organic coatings with polymeric coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mathematical Physics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW095122332A 2005-04-20 2006-06-21 Dendritic polymers with enhanced amplification and TWI356709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/013864 WO2006065266A2 (en) 2004-04-20 2005-04-20 Dendritic polymers with enhanced amplification and interior functionality

Publications (2)

Publication Number Publication Date
TW200801075A true TW200801075A (en) 2008-01-01
TWI356709B TWI356709B (en) 2012-01-21

Family

ID=37215167

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095122332A TWI356709B (en) 2005-04-20 2006-06-21 Dendritic polymers with enhanced amplification and

Country Status (6)

Country Link
EP (2) EP1877103A4 (zh)
JP (1) JP2008545621A (zh)
CA (1) CA2598430C (zh)
MX (1) MX2007010402A (zh)
TW (1) TWI356709B (zh)
WO (1) WO2006115547A2 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI557154B (zh) * 2015-07-02 2016-11-11 國立臺灣科技大學 超分子聚合物及其製作方法
CN113518757A (zh) * 2019-03-13 2021-10-19 伊士曼化工公司 可用于制造环十二硫的方法

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ550604A (en) * 2004-04-20 2010-09-30 Dendritic Nanotechnologies Inc Dendritic polymers with enhanced amplification and interior functionality
EP1991277A4 (en) * 2006-03-03 2010-12-22 Dendritic Nanotechnologies Inc DELIVERY OF BIOLOGICALLY ACTIVE MATERIALS WITH CORE-SHELL TECTO (DENDRITEN POLYMERS)
DE102006036326A1 (de) * 2006-08-03 2008-02-07 Charité - Universitätsmedizin Berlin Dendritische Polyglycerolsulfate und -sulfonate und deren Verwendung bei entzündlichen Erkrankungen
WO2008030591A2 (en) * 2006-09-08 2008-03-13 Dendritic Nanotechnologies, Inc. Peham dendrimers as excipients
US7939095B2 (en) * 2006-12-21 2011-05-10 Cordis Corporation Crosslinked silane coating for medical devices
EP1958624A1 (en) * 2007-02-16 2008-08-20 Freie Universität Berlin Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy
FR2925505B1 (fr) 2007-12-24 2010-04-02 Arkema France Procede de preparation d'un materiau forme de molecules arborescentes comportant des groupes associatifs
US8071679B2 (en) * 2008-02-29 2011-12-06 Ppg Industries Ohio, Inc Coating compositions comprising a polymer containing an oligomeric macromonomer
JP5093680B2 (ja) * 2008-06-26 2012-12-12 独立行政法人産業技術総合研究所 ビス四級アンモニウム塩コア型デンドリマー
FR2935836B1 (fr) * 2008-09-08 2012-11-23 Commissariat Energie Atomique Nanocristaux semi-conducteurs
GB0901857D0 (en) * 2009-02-05 2009-03-11 Nanoco Technologies Ltd Encapsulated nanoparticles
IT1393368B1 (it) * 2009-03-23 2012-04-20 Dipharma Francis Srl Metodo per la preparazione di rufinamide
AR076225A1 (es) 2009-04-07 2011-05-26 Dow Agrosciences Llc Administracion de nanoparticulas revestidas de una secuencia de nucleasa especifica
JP2011055751A (ja) * 2009-09-09 2011-03-24 Tokyo Univ Of Agriculture & Technology デンドリマー修飾磁気微粒子の製造方法
US8247151B2 (en) 2009-10-19 2012-08-21 Hewlett-Packard Development Company, L.P. Liquid toner, electrophoretic ink, and methods of making and use
WO2011053605A1 (en) * 2009-10-26 2011-05-05 Dendritic Nanotechnologies, Inc. Peham dendrimers for use in agriculture
US9296860B2 (en) 2009-12-21 2016-03-29 Dsm Assets B.V. Polymer, process and composition
MX2012013100A (es) 2010-05-18 2013-01-22 Cerulean Pharma Inc Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades.
FR2961208B1 (fr) * 2010-06-09 2012-11-23 Oreal Poly 2-pyrrolidones fonctionnalisees par un radical ester, acide ou amide, composition cosmetique les comprenant et leur utilisation comme agent dispersant
CA2808901A1 (en) * 2010-08-20 2012-02-23 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
IT1402520B1 (it) * 2010-10-19 2013-09-13 Ivm Chemicals Srl Rivestimento non nocivo attivo contro i microorganismi
EP3925625A1 (en) * 2011-01-09 2021-12-22 ANP Technologies, Inc. Hydrophobic molecule-induced branched polymer aggregates and their use
US9334351B2 (en) 2011-06-17 2016-05-10 Isp Investments Inc. 4- and 5-substituted 1,2,3-triazole, and regioisomer mixtures thereof, modified polymers
US20140228484A1 (en) * 2011-06-21 2014-08-14 Dsm Ip Asset B.V. Polymer, process and use
US20140200333A1 (en) * 2011-08-15 2014-07-17 Seta Biomedicals, Llc Dendron reporter molecules
WO2013087789A1 (en) 2011-12-13 2013-06-20 Glykos Finland Ltd. Antibody isoform arrays and methods thereof
JP5920024B2 (ja) * 2012-05-25 2016-05-18 Dic株式会社 フッ素化脂肪族基を含むスルホニルアミド化合物の製造方法及びアニオン性親水基含有界面活性剤の製造方法
AU2013274036B2 (en) 2012-06-14 2017-08-17 Dana-Farber Cancer Institute, Inc. Genome-wide method of assessing interactions between chemical entities and their target molecules
TWI524825B (zh) 2012-10-29 2016-03-01 財團法人工業技術研究院 碳材導電膜的轉印方法
WO2014136906A1 (ja) * 2013-03-06 2014-09-12 Ｊｘ日鉱日石エネルギー株式会社 摩擦調整剤および潤滑油組成物
JP6564369B2 (ja) * 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
JP6634547B2 (ja) 2014-05-21 2020-01-22 アイシーディー−セラピューティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 細胞内ターゲッティングのための硫酸化デンドリマーを有する治療複合体
US10202507B2 (en) 2014-05-29 2019-02-12 The University Of British Columbia Antithrombotic compounds, methods and uses thereof
CN115350285A (zh) 2014-08-13 2022-11-18 约翰霍普金斯大学 树枝状聚合物到脑肿瘤的选择性传递
US10968176B2 (en) 2014-09-14 2021-04-06 Nanosynthons Llc Pyrrolidone derivatives, oligomers and polymers
EP3194365A4 (en) * 2014-09-14 2018-04-25 Nanosynthons LLC Pyrrolidone derivatives, oligomers and polymers
WO2016046847A1 (en) 2014-09-23 2016-03-31 Council Of Scientific & Industrial Research Metal embedded hydrophilic polymer for drug delivery applications
CN104928919B (zh) * 2015-07-10 2017-03-08 广州大学 一种柔软协同抗菌刷型多季铵盐织物整理剂及其制备方法
JP6856662B2 (ja) 2015-12-16 2021-04-07 プライオスター プロプライアタリー リミティド デンドリマー及びその製剤
WO2018201007A2 (en) 2017-04-27 2018-11-01 The Johns Hopkins University Dendrimer compositions for use in angiography
AU2018365250B2 (en) 2017-11-10 2022-05-26 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
US11878969B2 (en) 2018-07-23 2024-01-23 Covestro (Netherlands) B.V. Multi-aziridine compound
US10954346B2 (en) 2018-12-27 2021-03-23 Industrial Technology Research Institute Resin and ink
CN110694599A (zh) * 2019-09-26 2020-01-17 浙江海洋大学 一种聚丙烯亚胺修饰的磁性纳晶纤维素分子印迹聚合物的制备方法
US11612660B2 (en) 2019-12-04 2023-03-28 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye
US20230140764A1 (en) 2020-01-22 2023-05-04 Covestro (Netherlands) B.V. Aziridine functional compound
CN111440824B (zh) * 2020-05-26 2022-07-12 北京化工大学 一种基于乳糖通过氨基-环氧开环反应构建肝靶向阳离子基因载体及其制备方法
CN111848969A (zh) * 2020-07-27 2020-10-30 洛阳理工学院 一种超支化双功能星型化合物、聚合物电解质材料及制备与应用
CN113698549B (zh) * 2021-09-03 2024-05-14 上海昶法新材料有限公司 超支化聚合物及其制备方法、应用、洗涤产品
CN116023669B (zh) * 2021-10-27 2023-12-15 兰州大学 一种杂臂超分子星形共聚物、其制备方法与应用
CN114044907B (zh) * 2021-12-15 2022-11-11 兴宇汽车零部件股份有限公司 一种膨胀阻燃功能化poss阻燃剂及其制备方法
CN114606190A (zh) * 2022-03-08 2022-06-10 东南大学 用于细胞杀伤及出泡的纳米试剂、细胞微米囊泡及其制备方法和应用
CN114632194B (zh) * 2022-04-11 2023-05-23 东莞市人民医院 具有长效no催化释放的涂层材料及制备方法和应用
CN115044008B (zh) * 2022-06-01 2024-01-05 武汉中科先进材料科技有限公司 一种亲水型阳离子光固化树脂及其制备方法和应用
CN115057552B (zh) * 2022-06-23 2023-06-02 先导薄膜材料有限公司 一种低浓度硝酸铵废水浓缩方法
CN115678271B (zh) * 2022-11-02 2023-08-22 常州大学 一种生物基聚酰胺植物染料色母粒的制备方法
CN116120575A (zh) * 2023-01-09 2023-05-16 汕头大学 一种二氧化硅接枝聚合物及其制备方法与应用
CN117946349A (zh) * 2024-03-26 2024-04-30 潍坊弘润新材料有限公司 一种树枝状聚合物改性羟基丙烯酸乳液、制备方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361337A (en) 1979-05-15 1982-11-30 Adriel Montes Piston ring with tongue and groove joint
US4631337A (en) 1983-01-07 1986-12-23 The Dow Chemical Company Hydrolytically-stable dense star polyamine
US4737550A (en) 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
IL69558A (en) 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4740585A (en) 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US5338532A (en) 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
IL83567A (en) * 1986-08-18 1992-02-16 Dow Chemical Co Starburst conjugates with a carried material,such as an agricultural or pharmaceutical material
US4735799A (en) 1987-01-14 1988-04-05 Patarroyo Manuel E Malaria vaccine
US5773527A (en) 1990-08-27 1998-06-30 Dendritech, Inc. Non-crosslinked, polybranched polymers
US5631329A (en) 1990-08-27 1997-05-20 Dendritech, Inc. Process for producing hyper-comb-branched polymers
JPH08510761A (ja) 1994-03-07 1996-11-12 ザ・ダウ・ケミカル・カンパニー 生物活性及び／又はターゲテッドデンドリマー複合体
SE503342C2 (sv) * 1994-10-24 1996-05-28 Perstorp Ab Hyperförgrenad makromolekyl av polyestertyp samt förfarande för dess framställning
IT1277596B1 (it) * 1995-09-15 1997-11-11 Bracco Spa Composti macromolecolari di tipo dendrimerico
US5760142A (en) * 1996-12-04 1998-06-02 Dentsply Detrey G.M.B.H. Epoxide-amine dendrimers and the preparation and use thereof
FR2790642A1 (fr) * 1999-03-08 2000-09-15 Aventis Cropscience Sa Nouvelles compositions pesticides et/ou regulatrices de croissance
GB0125216D0 (en) * 2001-10-19 2001-12-12 Univ Strathclyde Dendrimers for use in targeted delivery
NO322724B1 (no) * 2004-04-15 2006-12-04 Sinvent As Fremgangsmåte til fremstilling av polyforgrenet organisk/uorganisk hybridpolymer
NZ550604A (en) * 2004-04-20 2010-09-30 Dendritic Nanotechnologies Inc Dendritic polymers with enhanced amplification and interior functionality

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI557154B (zh) * 2015-07-02 2016-11-11 國立臺灣科技大學 超分子聚合物及其製作方法
CN113518757A (zh) * 2019-03-13 2021-10-19 伊士曼化工公司 可用于制造环十二硫的方法

Also Published As

Publication number Publication date
CA2598430C (en) 2011-10-25
EP1877103A4 (en) 2010-11-03
WO2006115547A8 (en) 2007-02-15
MX2007010402A (es) 2008-01-22
JP2008545621A (ja) 2008-12-18
EP2325236A1 (en) 2011-05-25
WO2006115547A3 (en) 2009-06-04
CA2598430A1 (en) 2006-11-02
TWI356709B (en) 2012-01-21
EP1877103A2 (en) 2008-01-16
WO2006115547A2 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
TW200801075A (en) Dendritic polymers with enhanced amplification and interior functionality
WO2006065266A3 (en) Dendritic polymers with enhanced amplification and interior functionality
Santos et al. Polyurethane foam impregnated with lignin as a filler for the removal of crude oil from contaminated water
Wang et al. A novel lignin/ZnO hybrid nanocomposite with excellent UV-absorption ability and its application in transparent polyurethane coating
Wang et al. In situ synthesis of flowerlike lignin/ZnO composite with excellent UV-absorption properties and its application in polyurethane
TW200728406A (en) Dendritic polymers with enhanced amplification and interior functionality
CN107949577B (zh) 改性纤维素纤维
Burnat et al. Composite membranes for alkaline electrolysis based on polysulfone and mineral fillers
Su et al. Mechanical properties research and structural characterization of alkali lignin/poly (vinyl alcohol) reaction films
ATE471758T1 (de) Teilchenförmige zusammensetzungen und ihre herstellung
TW200702376A (en) Molding composition comprising polyethylene for preparing films and process for preparing the molding composition in the presence of a mixed catalyst
Koschine et al. Correlation of gas permeation and free volume in new and used high free volume thin film composite membranes
Mishra et al. Effect of peptizer on the properties of Nafion–Laponite clay nanocomposite membranes for polymer electrolyte membrane fuel cells
Zuo et al. Engineering styrenic blends with poly (lactic acid)
Vilela et al. Exploiting poly (ɛ‐caprolactone) and cellulose nanofibrils modified with latex nanoparticles for the development of biodegradable nanocomposites
CN110003532A (zh) 一种植物纤维发泡缓冲材料的制备方法
Schoustra et al. Raman Spectroscopy Reveals Phase Separation in Imine-Based Covalent Adaptable Networks
Sriram et al. Recent progress in anion exchange membranes (AEMs) in water electrolysis: synthesis, physio-chemical analysis, properties, and applications
Prochukhan et al. Room temperature fabrication of macroporous lignin membranes for the scalable production of black silicon
Kettunen Cellulose nanofibrils as a functional material
CN107955534A (zh) 防霉型聚氨酯改性沥青防水涂料及其制备方法
AR057390A1 (es) Polimeros dendriticos con amplificacion aumentada y funcionalidad interior
KR20110007703A (ko) 폴리에틸렌/목분/점토 나노복합체
Dos Santos et al. Proton Exchange Membranes from Sulfonated Lignin Nanocomposites for Redox Flow Battery Applications
Fink The Chemistry of Environmental Engineering

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees